Europe — EMA
Moxonidin Hexal (Moxonidine)
GNH USA supplies Moxonidin Hexal (Moxonidine), a imidazoline receptor agonist for hypertension. Request a quote for global supply with reliable delivery.
Request sourcing
What is Moxonidine?
Moxonidine, the active ingredient in Moxonidin Hexal, is an imidazoline receptor agonist presented as an oral tablet for systemic use. It selectively reduces sympathetic nervous system activity, helping to lower elevated blood pressure in adults with hypertension. The medication is formulated for once-daily administration and is approved for prescription use in the European Union.
GNH USA supplies Moxonidin Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and research institutions worldwide through robust quality assurance processes and timely logistics.
What is Moxonidine used for?
Moxonidine is used to manage hypertension by acting on central imidazoline receptors that control sympathetic tone.
Hypertension: lowers elevated blood pressure in patients with primary hypertension. Essential hypertension: provides sustained blood pressure control in adults with essential hypertension. Resistant hypertension: offers an additional therapeutic option for patients whose blood pressure remains uncontrolled despite other antihypertensive agents.
What are the side effects of Moxonidine?
Moxonidine may cause a range of adverse reactions, which are categorized by frequency and severity.
Common Side Effects: - Dry mouth: sensation of oral dryness. - Fatigue: feeling of tiredness. - Dizziness: light‑headedness, especially on standing.
Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Bradycardia: abnormally slow heart rate. - Allergic reactions: rash, itching, swelling, or anaphylaxis.
What precautions apply to Moxonidine?
When prescribing Moxonidin Hexal, clinicians should consider several precautionary measures to ensure safe use. - Blood pressure monitoring: regularly assess to avoid excessive hypotension. - Renal impairment: adjust dose in patients with moderate to severe kidney dysfunction. - Diabetes mellitus: monitor glucose as sympathetic inhibition may affect glycemic control. - Elderly patients: start with lower dose and titrate cautiously. - Concomitant antihypertensives: evaluate for additive blood‑pressure lowering effects. - Store at ambient temperature: keep in original container, protect from moisture and heat.
What does Moxonidine interact with?
Moxonidine can interact with other medicines, influencing its antihypertensive effect or safety profile.
Major Interactions (Avoid): - Clonidine: combined use may cause additive hypotensive effects. - MAO inhibitors: risk of severe hypotension when used together.
Moderate Interactions (Monitor Closely): - Diuretics: may enhance blood‑pressure reduction. - Beta‑blockers: additive effect on heart rate and blood pressure. - Calcium channel blockers: possible potentiation of hypotensive response. - NSAIDs: may attenuate the antihypertensive efficacy of moxonidine.



